Home/Avstera Therapeutics/Karthik Musunuri
KM

Karthik Musunuri

Founder, Chief Executive Officer & Director

Avstera Therapeutics

Avstera Therapeutics Pipeline

DrugIndicationPhase
AVS100Locally advanced or metastatic solid tumorsPhase 1
Next-Gen Oral HDAC6iCardiometabolic & Cardiovascular diseasesPreclinical